0
What is the maximum plasma level of tamoxifen that can be achieved in breast cancer patients?
- 1 people answered
0 Vote
1 Contributor
1508 Views 
0 Saved
0 Vote 1 Contributor1508 Views 0 SavedYou might also be interested in
treatment for tumor in the liver depends on the kind of tumor and its extent. please share your reports for a better advice.
It completely depends on the situation. In Kyphoplasty, either a spine surgeon or an interventional radiologist tries to treat a vertebral fracture using surgical cement. It effectively reduces the pain. In case of a cancer patient, the process accompanies radiofrequency ablation to remove cancer ti....
Yes…!! It is safe for health. This fruit looks like a small pumpkin and is green to pale yellow in colour. It is one of the most popular natural diet supplements. It contains Hydroxy citric acid (HCA) that is obtained from its rind and it is capable of burning fats much faster than other supple....
Mithun Kumar
Tamoxifen is a highly effective endocrine treatment for breast cancer in the adjuvant and metastatic settings. Data from several large randomized clinical trials indicate that tamoxifen is also valuable in the prevention of breast cancer in women at high risk for the disease. However, not all women benefit from tamoxifen, and the side effect profiles vary considerably from patient to patient.
Tamoxifen treatment promotes significant changes both in the plasma concentration of an important marker associated with an increased risk of Cardio Vascular Disease (CVD) and in functional parameters of cardiac performance in women with breast cancer who have previously undergone chemotherapy. Previous studies had also confirmed the cardiotoxic effects of chemotherapy.
Chronic use of tamoxifen significantly reduces the plasma concentrations of CVD biomarkers (CRP, Apo B, and the Apo-B/Apo-A ratio) in women with breast cancer who underwent chemotherapy. Several study suggests the need for a careful cardiovascular evaluation and the medical monitoring of women with breast cancer to reduce the morbidity and mortality associated with cancer treatment complications.